Development and Validation of a Polygenic Hazard Score to Predict Prognosis and Adjuvant Chemotherapy Benefit in Early-Stage Non-Small Cell Lung Cancer.
Translational Lung Cancer Research（2022）
Key words
Non-small cell lung cancer (NSCLC),polygenic hazard score (PHS),predict,adjuvant chemotherapy,benefit
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined